Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark
Search for other papers by Simon Chang in
Google Scholar
PubMed
Search for other papers by Arkadiusz J Goszczak in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
Search for other papers by Jens Fedder in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Search for other papers by M Vakur Bor in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Search for other papers by Moniek P M de Maat in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed
positive association between fibrin clot lysis and testosterone levels. Subgroup analysis in KS or controls alone fell short of being statistically significant, potentially due to power issues. We have previously published epidemiological data supporting
Search for other papers by Run-Qing Xiong in
Google Scholar
PubMed
Search for other papers by Yan-Ping Li in
Google Scholar
PubMed
Search for other papers by Lu-Ping Lin in
Google Scholar
PubMed
Search for other papers by Jeng-Yuan Yao in
Google Scholar
PubMed
the recognition and management of diabetic cardiomyopathy . Journal of the American College of Cardiology 2018 71 339 – 351 . ( https://doi.org/10.1016/j.jacc.2017.11.019 ) 15 Zhang A Sun H & Wang X . Power of metabolomics in biomarker
Search for other papers by Yumei Zhai in
Google Scholar
PubMed
Search for other papers by Haiming Fu in
Google Scholar
PubMed
Search for other papers by Yu Li in
Google Scholar
PubMed
Search for other papers by Siyuan Li in
Google Scholar
PubMed
Search for other papers by Wenchen Zhang in
Google Scholar
PubMed
Search for other papers by Jianwei Yue in
Google Scholar
PubMed
Search for other papers by Zichao Wang in
Google Scholar
PubMed
with markers related to glucose and lipid metabolism in TyG-BMI and METS-IR may provide a more holistic assessment of metabolic health, potentially enhancing their predictive power. Limitations First, due to the retrospective nature of the study
Search for other papers by Mette Faurholdt Gude in
Google Scholar
PubMed
Steno Diabetes Centre Odense, Odense University Hospital, Odense, Denmark
Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Search for other papers by Mette Bjerre in
Google Scholar
PubMed
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Morten Haaning Charles in
Google Scholar
PubMed
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Daniel R Witte in
Google Scholar
PubMed
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Annelli Sandbæk in
Google Scholar
PubMed
Search for other papers by Jan Frystyk in
Google Scholar
PubMed
slightly lower number of events in this group, thus resulting in reduced analytical power. Conclusion This study demonstrates an association between PAPP-A and CVD in patients with T2D. In addition, we could demonstrate that all components of the